Serial Number | 90695869 |
Word Mark | ONEGENE PROGRAM |
Filing Date | Friday, May 7, 2021 |
Status | 700 - REGISTERED |
Status Date | Tuesday, January 9, 2024 |
Registration Number | 7270239 |
Registration Date | Tuesday, January 9, 2024 |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, February 22, 2022 |
Description of Mark | The mark consists of the word "ONEGENE" with the word "ONE" in dark blue followed by and the word "GENE" in light blue above the word "PROGRAM" in gray. |
Pseudo Mark | ONE GENE PROGRAM |
Goods and Services | Providing information regarding insurance coverage and reimbursement for prescription drugs; financial administration of a patient assistance program for providing prescription drugs at reduced cost |
Indication of Colors claimed | The color(s) dark blue, light blue and gray is/are claimed as a feature of the mark. |
Goods and Services | Business administration of a patient assistance program for providing prescription drugs at reduced cost |
Disclaimer with Predetermined Text | "PROGRAM" |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, August 9, 2021 |
Primary Code | 035 |
First Use Anywhere Date | Thursday, May 6, 2021 |
First Use In Commerce Date | Thursday, May 6, 2021 |
International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, August 9, 2021 |
Primary Code | 036 |
First Use Anywhere Date | Thursday, May 6, 2021 |
First Use In Commerce Date | Thursday, May 6, 2021 |
Party Name | Novartis AG |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | Basel 4002 CH |
Party Name | Novartis AG |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Basel 4002 CH |
Party Name | Novartis AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Basel 4002 CH |
Event Date | Event Description |
Tuesday, January 9, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, January 9, 2024 | REGISTERED-PRINCIPAL REGISTER |
Saturday, December 2, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Friday, December 1, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Tuesday, November 28, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, November 28, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, November 28, 2023 | ASSIGNED TO LIE |
Tuesday, November 7, 2023 | ASSIGNED TO EXAMINER |
Friday, June 23, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, May 23, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, May 23, 2023 | NON-FINAL ACTION E-MAILED |
Tuesday, May 23, 2023 | SU - NON-FINAL ACTION - WRITTEN |
Tuesday, May 2, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
Wednesday, April 12, 2023 | USE AMENDMENT FILED |
Monday, May 1, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Wednesday, April 12, 2023 | TEAS STATEMENT OF USE RECEIVED |
Thursday, October 6, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, October 4, 2022 | SOU EXTENSION 1 GRANTED |
Tuesday, October 4, 2022 | SOU EXTENSION 1 FILED |
Tuesday, October 4, 2022 | SOU TEAS EXTENSION RECEIVED |
Tuesday, April 19, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, February 22, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, February 22, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, February 2, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, January 18, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, January 18, 2022 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, January 18, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, January 18, 2022 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, January 18, 2022 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, January 12, 2022 | ASSIGNED TO EXAMINER |
Monday, August 9, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, May 11, 2021 | NEW APPLICATION ENTERED |